[ Skip to main content ]
This article is over 3 years old

The New Zealand Drug Foundation today released its policy on medicinal cannabis, supporting the medical use of cannabis under a trial regime.

The policy urges the Government to implement a 'compassionate regime' to allow the use of cannabis in limited circumstances.

"The evidence from around the world is now well-enough established to show that cannabis does have a therapeutic value in treating certain medical conditions," said Drug Foundation executive director Ross Bell.

"The government should lay the policy groundwork to initiate a compassionate regime, to allow patients to use cannabis when it is recommended by an approved medical practitioner.

"Cannabis is being shown to be effective at treating a range of conditions, from chronic pain, neurological disorders like multiple sclerosis, chemotherapy side-effects such as nausea and vomiting and helps stimulate appetites.

"In addition, cannabis lacks many of the side-effects of currently available medications, and often people are prescribed even more drugs to alleviate the side-effects. The government must seriously consider the benefits of medicinal cannabis."

Mr Bell said that the Drug Foundation policy was cautious about the adverse effects of smoking cannabis, but until other treatments such as cannabis-derivative sprays became available it was the best delivery method for cannabinoids.

"Let's be clear on this," said Mr Bell. "This is not a backdoor for decriminalisation of cannabis, these are entirely separate issues. We are only interested in providing a compassionate form of pain relief for thousands of New Zealanders.

"Although there is the legislative ability for the Health minister to approve the use of cannabis on an individual basis, this has never happened. Our policy would establish a tightly-controlled regime to investigate each individual's circumstances."

The Drug Foundation's policy would establish an Expert Advisory Committee on Medicinal Cannabis, which would monitor the evidence and research, and evaluate the effectiveness of the compassionate regime after a three-to-five year period.

This article is over 3 years old
Share this article:
Share:

Related See more

CBD Oil

D-Day approaches for new medicinal cannabis scheme

The number of products are set to be slashed and prices are expected to spike when a transitional medicinal cannabis scheme expires in Octob...

Dr Reti’s medicinal cannabis bill highlights flaws in current system

Private members bill from Dr Shane Reit highlights how the current medicinal scheme has left patients with huge barriers to access.

Public health experts call for yes vote in referendum

A new editorial published in the NZMJ explores why a yes vote offers a net gain for public health.

thumbnail news

Cannabis legalisation could boost public health funding, Government reports show

Massive funding opportunities for public health under cannabis legalisation, Government reports show

The Level promo

Straight up guide for people who use drugs

The Level is for real people, in real life, whatever level they are at.

The Level

social graphic subscribe

Subscribe to email updates

Get regular news, analysis and commentary on drug issues in New Zealand. Free.

Sign up now!

Back to top